Navigation Links
Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report
Date:8/24/2010

and other high priority biodefense pathogens, including plague and tularemia. The FDA has designated Restanza as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, as well as for use in treating plague and tularemia, but the drug is not yet approved for these or any other indications.

Advanced Life Science recently announced that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of Restanza to treat CABP.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections including CABP and biodefense pathogens including anthrax, plague and tularemia. For more information, please visit us on the web at www.advancedlifesciences.com or follow us on twitter at http://twitter.com/advancedlifesci.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements represent our management's judgment regarding future events.  The Company does not undertake any obligations to update any forward-looking statements whether as a result of new information, future events or otherwise.  Our actual results could differ materially from those discussed herein due to several factors including the success and timing of our clinical trials and our ability to obtain
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CVS Health Corporation (NYSE: CVS ) ... 1, 2015, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call will ... the CVS Health website for all interested parties. To ... will be archived and available on the web site ...
(Date:4/17/2015)... GENEVA , April 17, 2015 ... for EGFR mutation   is a viable alternative to tumour ... mutation testing in all patients with advanced NSCLC   ... the effectiveness of plasma circulating tumour DNA (ctDNA) testing for ... patients with advanced non-small cell lung cancer (NSCLC) in clinical ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Mammography Equipment - Global Strategic Business Report" ... the worldwide markets for Mammography Equipment in US$ Thousands ... Digital Mammography Equipment. The report provides separate comprehensive analytics ... Japan , Europe , ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... , ... REYKJAVIK, Iceland, December 16 Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ) ... single-letter variant in the sequence of,the human genome (SNP) with a major ... variant is not only large, but unusual:,if an individual inherits it from ...
... , , PITTSBURGH, Dec. 16 ... first patient in a study of its lead surgical ... major milestone in the company,s progression of the lead ... is a prospective, open-label, randomized study to investigate the ...
Cached Medicine Technology:deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3
(Date:4/17/2015)... 2015 From the day Dr. Todd Phillips ... non-profit organization has empowered young people to create meaningful change ... bring fresh water and the Gospel to all of Liberia ... March 17 and 27, students, faculty and staff raised $21,000 ... fresh water and the Good News of Jesus. , ...
(Date:4/17/2015)... 2015 Consumers who prefer to have ... can now use the Insurance Pros USA website for ... rates that are featured by leading companies quoting plans ... are offered are mixed between three of the most ... There are now term, universal and whole policies that ...
(Date:4/17/2015)... Grand Rapids, MI (PRWEB) April 17, 2015 ... for CRUSH Grand Rapids, Saturday, April 25, 2015. The event ... at Reserve Wine & Food (201 Monroe Ave NW, Grand ... chefs from around the West Michigan area. Patrons are encouraged ... night of elegance and fun. , This year’s event will ...
(Date:4/17/2015)... 17, 2015 At the end of ... and the “Salute to the Oscars” in the Stardust ... Hotel, overlooking the impressive Los Angeles skyline. These events ... Debbie Durkin, LA’s leading producer of sustainable product placement ... the world’s premier providers of eco-friendly and socially conscious ...
(Date:4/17/2015)... 17, 2015 Testosterone treatment lawsuits ... of prescription medications increases the likelihood that a ... other life-threatening cardiovascular event continue to mount in ... Northern District of Illinois. According to an updated ... on Multidistrict Litigation (JPML) on April 15th, 1,382 ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4
... Keralites have a weak heart, said a city cardiologist Tuesday. ... In other parts of the country things are better than ... ,According to Chandran, high metabolic syndrome and a combination ... and cholesterol lead to a weak heart. ...
... than 200 children were taken ill after eating lunch at ... students were admitted to a hospital and are reportedly in ... of Dianshi Town High School began reporting symptoms of headache, ... school Monday and were immediately hopitalised. ,The food ...
... Doctors at the Government Homeopathic Medical College in Kozhikode ... Principal Abdul Rehman said in a release that several ... chikungunya. ,He added at a one-day seminar in ... already distributed these medicines to two lakh patients. Tamil ...
... integral part of health, and assessment of sleep habits should ... editorial in the September 18 issue of Archives of Internal ... is devoted to studies of sleep and health. ... serves as an indicator of health and quality of life ...
... bottles of Similac Infant Formula were off the shelf, after ... following a suspected flaw in the bottle. No repercussions after ... the company has decided to recall the product in order ... C content in the bottle. ,Given ...
... coffee mugs, notepads, pens and tote bags adorned with ... offices.// ,The rules, expected to take effect from Oct. ... Stanford University to accept any gifts, irrespective of its ... or related products. ,Besides this the university ...
Cached Medicine News:Health News:Incorporate Sleep Evaluation into Routine Medical Care 2Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 2Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 3Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 4
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
... The new Primus PDQ Plus for the ... fast and accurate results. The PDQ Plus is ... and on-line barcode reading for the ultimate in ... boronate affinity which is well known to be ...
... laboratorys productivity through expanded ... workflow management. The first ... now completely integrates clinical ... specimen processing management, centrifugation ...
... STart 4 semi-automated hemostasis analyzer features ... clot detection (Viscosity-based Detection System). This ... or other optically turbid samples or ... programmable and preprogrammed assays with calibration ...
Medicine Products: